|
|
Volumn 24, Issue 6, 1999, Pages 629-646
|
|
Design and synthesis of a novel class of highly potent, selective and orally active nonpeptide bradykinin B2 receptor antagonists
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[4 [4 (AMINOIMINOMETHYL)BENZOYL] 1 PIPERAZINYL]CARBONYL] 1 [2,4 DICHLORO 3 [(2,4 DIMETHYL 8 QUINOLINYL)OXYMETHYL]PHENYLSULFONYL]PYRROLIDINE;
3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE;
3 BROMO 8 [2,6 DICHLORO 3 [N [4 (N,N DIMETHYLCARBAMOYL)CINNAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYLIMIDAZO[1,2 A]PYRIDINE;
[[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE;
BRADYKININ B2 RECEPTOR ANTAGONIST;
DELTIBANT;
DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO PHENYLALANINE];
ICATIBANT;
LF 160687;
UNCLASSIFIED DRUG;
BINDING AFFINITY;
CONFORMATIONAL TRANSITION;
DRUG DESIGN;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
INFLAMMATORY DISEASE;
LUNG SMALL CELL CANCER;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
REVIEW;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0032784166
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.1999.024.06.545142 Document Type: Review |
|
Times cited : (13)
|
|
References (37)
|
